07/15/2025 15:01
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled tria...

Topshots of the Week (1-7 July, 2023)

Selection of some of the most striking photographs taken by AFP photojournalists this past week (1-7 July, 2023).


Stork fly over a burning field in Ukraine

Stork fly over a burning field near town of Snigurivka, Mykolaiv region on July 4, 2023, amid Russian invasion in Ukraine.
© Anatolii STEPANOV / AFP

Topshots of the Week (17-23 June, 2023)

Selection of some of the most striking photographs taken by AFP photojournalists this past week (17-23 June, 2023).


Boy covers himself with a cloth, India

A boy covers himself with a cloth while walking along a street, as it rains in Chennai on June 19, 2023.
© R.Satish BABU / AFP